DXSP:F:F-Xtrackers - Euro Stoxx 50 Short Daily Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.157

Change

-0.18 (-2.79)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.60 (+0.47%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.60 (+1.15%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.64 (+1.14%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.31 (+2.02%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+0.83 (+0.85%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.40 (+0.60%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

-0.04 (-0.59%)

USD 41.48B
0ZC:F Zscaler Inc

+12.10 (+6.94%)

USD 37.92B
BSND:F Danone SA

+0.40 (+2.92%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing DXSP:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -10.34% 10% F 29% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.34% 10% F 28% F
Trailing 12 Months  
Capital Gain -7.29% 13% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.29% 11% F 33% F
Trailing 5 Years  
Capital Gain -64.50% 1% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.50% 1% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain -12.68% 5% F 17% F
Dividend Return -12.68% 5% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.12% 63% D 89% A-
Risk Adjusted Return -114.01% 1% F 1% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.